Designed for all etiologies with proven results

125000 devices distributed
Gore TEVAR leadership
5-year follow up data

* Consolidated site reported outcomes following 5 years of follow-up in TAG 08-01, TAG 08-02, and TAG 08-03 clinical studies.

W. L. Gore & Associates. 'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation. Bethesda, MD: National Library of Medicine; 2012. Available from: https://clinicaltrials.gov/ct2/show/NCT01658787 . NLM Identifier: NCT01658787. Published August 3, 2012. Updated: September 8, 2017. Accessed August 27, 2018.

W. L. Gore & Associates. Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection. Bethesda, MD: National Library of Medicine; 2009. Available from: https://clinicaltrials.gov/ct2/show/NCT00908388 . NLM Identifier: NCT00908388. Published May 25, 2009. Updated October 27, 2017. Accessed August 27, 2018.

W. L. Gore & Associates. Evaluation of the GORE Conformable TAG® for Treatment of Traumatic Transection. Bethesda, MD: National Library of Medicine; 2009. Available from https://clinicaltrials.gov/ct2/show/NCT00917852 . NLM Identifier: NCT00917852. Published June 10, 2009. Updated August 25, 2017. Accessed August 27, 2018.

W. L. Gore & Associates. To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease. Bethesda, MD: National Library of Medicine; 2008. Available from: https://clinicaltrials.gov/ct2/show/NCT00757003 . NLM Identifier: NCT00757003. Published September 22, 2008. Updated March 1, 2017. Accessed August 27, 2018.